Literature DB >> 28247118

Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients?

Hanzade Aybüke Ünal-Artık1, Levent Ertuğrul İnan2, Ceyla Ataç-Uçar3, Tahir Kurtuluş Yoldaş3.   

Abstract

We aimed to compare the effectiveness of bilateral and unilateral block application in chronic migraine patients and whether there were differences in their effectiveness retrospectively. In chronic migraine patients undergoing Greater occipital nerve (GON) block, mean number of days with pain per month before and after block, mean duration of pain in attacks (in hours), and mean Visual Analog Scale (VAS) in attack and pain severity were recorded from files. The patients underwent one block a week for the first 1 month, thereafter one block a month according to GON block protocol used by our institute. Of 41 patients included in the study, 23 underwent unilateral block (group 1) and 18 underwent bilateral block (group 2). In both groups, number of days with migraine decreased significantly in 2 and 3 months as compared to pre-block treatment (P < 0.001). Mean duration of headache decreased in group 2 during treatment (P < 0.001). In group 1, mean duration of headache also decreased but did not differ significantly (P = 0.051). Mean severity of migraine decreased significantly differ in group 1 in 2, 3 months as compared to pre-block treatment (P < 0.001). No differences were observed in frequency, severity and duration of headache between groups during 3-month treatment period. GON block is effective in chronic migraine and bilateral application is no superior over unilateral application.

Entities:  

Keywords:  Greater occipital nerve block; Headache; Migraine; Nerve block

Mesh:

Substances:

Year:  2017        PMID: 28247118     DOI: 10.1007/s10072-017-2861-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

1.  Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes.

Authors:  V Busch; W Jakob; T Juergens; W Schulte-Mattler; H Kaube; A May
Journal:  Cephalalgia       Date:  2006-01       Impact factor: 6.292

2.  Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients.

Authors:  C A Caputi; V Firetto
Journal:  Headache       Date:  1997-03       Impact factor: 5.887

3.  Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS).

Authors:  Andrew Blumenfeld; Avi Ashkenazi; Brian Grosberg; Uri Napchan; Samer Narouze; Bob Nett; Traci DePalma; Barbara Rosenthal; Stewart Tepper; Richard B Lipton
Journal:  Headache       Date:  2010-06       Impact factor: 5.887

4.  Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input.

Authors:  Thorsten Bartsch; Peter J Goadsby
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

5.  Greater occipital nevre block in migraine headache: preliminary results of 10 patients.

Authors:  Suna Akin Takmaz; Nurten Inan; Serap Uçler; Mehmet Akif Yazar; Levent Inan; Hülya Başar
Journal:  Agri       Date:  2008-01

Review 6.  Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.

Authors:  Andrew Blumenfeld; Avi Ashkenazi; Uri Napchan; Steven D Bender; Brad C Klein; Randall Berliner; Jessica Ailani; Jack Schim; Deborah I Friedman; Larry Charleston; William B Young; Carrie E Robertson; David W Dodick; Stephen D Silberstein; Matthew S Robbins
Journal:  Headache       Date:  2013-02-13       Impact factor: 5.887

7.  The first 5 minutes after greater occipital nerve block.

Authors:  William Young; Brianna Cook; Shahram Malik; James Shaw; Michael Oshinsky
Journal:  Headache       Date:  2008-06-28       Impact factor: 5.887

8.  Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study.

Authors:  A Ashkenazi; R Matro; J W Shaw; M A Abbas; S D Silberstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

9.  Occipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate.

Authors:  Joshua A Tobin; Stephen S Flitman
Journal:  Headache       Date:  2009 Nov-Dec       Impact factor: 5.887

10.  Cumulative lifetime migraine incidence in women and men.

Authors:  W F Stewart; C Wood; M L Reed; J Roy; R B Lipton
Journal:  Cephalalgia       Date:  2008-07-15       Impact factor: 6.292

View more
  5 in total

Review 1.  Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.

Authors:  Amr Menshawy; Hussien Ahmed; Ammar Ismail; Abdelrahman Ibrahim Abushouk; Esraa Ghanem; Ravikishore Pallanti; Ahmed Negida
Journal:  Neurol Sci       Date:  2017-09-23       Impact factor: 3.307

2.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

3.  Efficacy of ultrasound-guided greater occipital nerve pulsed radiofrequency therapy in chronic refractory migraine.

Authors:  Derya Guner; Can Eyigor
Journal:  Acta Neurol Belg       Date:  2022-06-02       Impact factor: 2.396

4.  Comparison of the clinical efficacy of bilateral and unilateral GON blockade at the C2 level in chronic migraine.

Authors:  Mustafa Karaoğlan; İsmail Eren Durmuş; Bilge Küçükçay; Suna Akın Takmaz; Levent Ertuğrul İnan
Journal:  Neurol Sci       Date:  2021-11-18       Impact factor: 3.830

5.  Management of refractory chronic migraine using ultrasound-guided pulsed radiofrequency of greater occipital nerve: Two case reports.

Authors:  Soyoung Kwak; Min Cheol Chang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.